190 related articles for article (PubMed ID: 32887355)
1. Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies.
Lachén-Montes M; Mendizuri N; Schvartz D; Fernández-Irigoyen J; Sánchez JC; Santamaría E
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887355
[TBL] [Abstract][Full Text] [Related]
2. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
3. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
5. Color Vision Impairment Differentiates Alzheimer Dementia From Dementia With Lewy Bodies.
Flanigan PM; Khosravi MA; Leverenz JB; Tousi B
J Geriatr Psychiatry Neurol; 2018 Mar; 31(2):97-102. PubMed ID: 29658429
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
7. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S
PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
[TBL] [Abstract][Full Text] [Related]
10. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
[TBL] [Abstract][Full Text] [Related]
11. Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis.
Segers K; Benoit F; Meyts JM; Surquin M
Psychogeriatrics; 2020 May; 20(3):242-246. PubMed ID: 31782249
[TBL] [Abstract][Full Text] [Related]
12. Prodromal dementia with Lewy bodies.
Fujishiro H; Nakamura S; Sato K; Iseki E
Geriatr Gerontol Int; 2015 Jul; 15(7):817-26. PubMed ID: 25690399
[TBL] [Abstract][Full Text] [Related]
13. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
Williams SS; Williams J; Combrinck M; Christie S; Smith AD; McShane R
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):667-70. PubMed ID: 19448090
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
Bousiges O; Bombois S; Schraen S; Wallon D; Quillard MM; Gabelle A; Lehmann S; Paquet C; Amar-Bouaziz E; Magnin E; Miguet-Alfonsi C; Delbeuck X; Lavaux T; Anthony P; Philippi N; Blanc F;
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):467-475. PubMed ID: 29321140
[TBL] [Abstract][Full Text] [Related]
15. Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
Cagnin A; Fragiacomo F; Camporese G; Turco M; Bussè C; Ermani M; Montagnese S
J Alzheimers Dis; 2017; 55(4):1529-1536. PubMed ID: 27886007
[TBL] [Abstract][Full Text] [Related]
16.
Kasanuki K; Iseki E; Ota K; Kondo D; Ichimiya Y; Sato K; Arai H
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):358-365. PubMed ID: 27480759
[TBL] [Abstract][Full Text] [Related]
17. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
Walker MP; Ayre GA; Cummings JL; Wesnes K; McKeith IG; O'Brien JT; Ballard CG
Neurology; 2000 Apr; 54(8):1616-25. PubMed ID: 10762503
[TBL] [Abstract][Full Text] [Related]
18. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
[TBL] [Abstract][Full Text] [Related]
19. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
20. Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies.
Breitve MH; Brønnick K; Chwiszczuk LJ; Hynninen MJ; Aarsland D; Rongve A
Alzheimers Res Ther; 2018 Aug; 10(1):83. PubMed ID: 30121084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
